In an era defined by medical innovation and groundbreaking therapies, a pioneering leader in the healthcare industry joined forces with FundamentalVR, the global authority in immersive surgical training, to revolutionize the traditional approach to onboarding gene therapy centers.
The conventional method involved physically bringing physicians and personnel to wet labs, which was both resource-intensive and limited in scope. Recognizing the need for a scalable and efficient solution, the two companies integrated the expertise of leading Key Opinion Leaders (KOLs) to develop an extraordinary Virtual Reality (VR) simulation.
Through the Fundamental Surgery platform, the partners worked in tandem to replace the need for physical wet labs during onboarding sessions, allowing for a seamless and global onboarding process for gene therapy centers. This innovative approach not only eliminated geographical constraints but also provided a cost-effective and time-efficient alternative to the traditional onboarding methods.
This allowed the company to conduct over 150 sessions in more than 30 countries, reaching corners of the world that were previously challenging to access. The impact of this global onboarding initiative was particularly crucial during the pandemic, enabling the company to continue delivering treatments to patients worldwide.
The significance of this achievement is underscored by the fact that without the efficient onboarding facilitated by the FundamentalVR simulator, gene therapy centers would have faced delays in their ability to treat patients. Particularly, in the case of this therapy, where timely intervention is important, the innovative approach has proven instrumental in overcoming barriers and ensuring the continued onboarding process.
This transformational partnership has showcased the strength of collaboration between a global healthcare leader and the foremost authority in immersive surgical training, underscoring the power of technology and innovation in advancing medical education and patient care.
